ProUroCare Medical

ProUroCare Medical Inc. is focused on developing advanced products for the identification and assessment of male prostate diseases. The company's flagship offering, the ProUroScan System, provides innovative imaging solutions for physicians to document prostate irregularities.

Products and Services

• ProUroScan System for prostate imaging
• Licensing agreements with Artann Laboratories Inc.
• Ongoing development and commercialization of prostate health solutions

Growth Outlook

• Strategic partnerships enhance market reach and product development
• Focus on expanding the prostate health product line
• Potential for increased demand in prostate disease diagnostics

Financial Highlights

• Recent quarterly revenue of $0 indicates early-stage development
• Trailing twelve months net income shows a loss of $1.5 million
• Current ratio of 0.055 indicates liquidity challenges

ProUroCare Medical Inc. operates in the consumer electronics sector, specifically targeting the healthcare market with its innovative prostate imaging technology. The ProUroScan System is designed to assist healthcare professionals in accurately diagnosing prostate conditions, which is critical given the rising awareness of prostate health issues. The company has established strategic agreements to facilitate the ongoing development and commercialization of its products, positioning itself for future growth. Despite facing financial challenges, including a recent quarterly revenue of $0 and a trailing twelve months net income loss, the company is focused on expanding its product offerings and enhancing its market presence. The current ratio indicates liquidity challenges, which may impact short-term operations. However, the strategic partnerships and focus on product development could provide a pathway for future growth and increased demand in the prostate health diagnostics market.